Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs propofol with sufentanil for laryngeal mask anesthesia without neuromuscular blockers
ChiCTR2400086601Phase 4Recruiting
- Sponsor
- Weihai Municipal Hospital
- Start
- Jul 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of remimazolam in None (2 arms), sponsored by Weihai Municipal Hospital. Primary endpoint: Summed scores of LMA insertion conditions. Started Jul 2024; status: recruiting.
02
Drugs
remimazolam
Beyond the preview
Go deeper on ChiCTR2400086601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400086601.